Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Melanoma 3Cholangiocarcinoma 3Breast Neoplasms 3Sarcoma 2Osteosarcoma 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unresectable Solid Tumors 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroblastoma 1Lung Neoplasms 1Liver Metastasis 1High-Burden Metastatic Solid Tumors 1Hepatoblastoma 1Gastric Cancer Metastatic to Liver 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoid Tumors 1Colonic Neoplasms 1

Interventions

Gemcitabine 83Cisplatin 59pembrolizumab 28Paclitaxel 21Nivolumab 21Carboplatin 21Cystectomy 20Docetaxel 18durvalumab 17atezolizumab 17Magnetic Resonance Spectroscopy 16Specimen Handling 15Radiotherapy 14avelumab 13Mitomycin 13Sunitinib 12Doxorubicin 12Methotrexate 11Fluorouracil 11Vinblastine 10Filgrastim 7BCG Vaccine 7Sorafenib 6Ipilimumab 6Immunoglobulin G 6Disulfides 6Biopsy 6enfortumab vedotin 5cabozantinib 5Trastuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Urinary Bladder Neoplasms × Cryosurgery × Clear all
NCT04701918 2026-01-22

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Massachusetts General Hospital

Phase 2 Completed
9 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡